The Next Frontier in Cancer & Longevity: NK Cell–Derived Exosomes with Dr. Jeff Gross |ANEW 102

In this powerful second half of the ANEW Insight Podcast interview, Dr. Supatra Tovar continues her conversation with board-certified neurosurgeon and founder of ReCELLebrate, Dr. Jeff Gross, diving even deeper into the groundbreaking potential of natural killer (NK) cell–derived exosomes for cancer prevention, remission support, and longevity.

Dr. Gross explains how NK exosome therapy may benefit individuals with genetic or high epigenetic risk profiles, offering a preventative or maintenance tool for those exposed to higher cancer risks due to environment, lifestyle, or occupational hazards. Backed by promising research from Europe and Asia, NK exosomes have shown remarkable results in both solid tumors and bloodborne cancers, often without the side effects of chemotherapy or radiation.

Listeners will discover how these therapies are being applied to shrink tumors, eliminate circulating cancer cells, and support immune rejuvenation—potentially changing the way cancer is treated and prevented. Dr. Gross shares insights from his network of regenerative medicine specialists, covering complementary treatments such as high-dose intravenous vitamin C, phytonutrient-rich berries, and repurposed pharmaceuticals like ivermectin and mebendazole.

The episode explores the current barriers to widespread access in the U.S., including limited supply, labor-intensive harvesting, and regulatory restrictions on marketing claims. Dr. Gross outlines how precision medicine—using targeted injections guided by advanced imaging—can deliver exosomes directly to tumors, sparing the rest of the body from unnecessary toxicity.

Beyond oncology, Dr. Gross discusses the role of NK and stem cell–derived exosomes in anti-aging and biohacking. From improving bone density and joint health to boosting energy, enhancing cognitive clarity, and even promoting hair follicle regeneration, exosome therapy is proving to be a multi-dimensional tool for extending both lifespan and healthspan. He also explains how biological age testing, hormonal optimization, and personalized lifestyle adjustments can amplify the benefits of regenerative therapies.

This candid conversation covers everything from the science of immune activation to the real-world results experienced by Dr. Gross’s patients—and even his own personal biohacking journey. With applications in cancer care, chronic illness, joint repair, and overall vitality, NK exosome therapy could be a defining innovation in 21st-century medicine.

You want to know more about him. Here are his social media links: https://recellebrate.com/back-pain-doctor/, https://www.instagram.com/ifixspines/?hl=en, https://www.linkedin.com/in/jeff-gross-md-5605605

If you’ve ever wondered what the next frontier in regenerative oncology and longevity science might look like, this episode offers both the inspiration and the information to

Thank you for joining us on this journey to wellness. Remember, the insights and advice shared on the ANEW Body Insight Podcast are for educational and informational purposes only and do not constitute medical advice. Always consult with a healthcare professional before making any changes to your health routine. To learn more about the podcast and stay updated on new episodes, visit ANEW Body Insight Podcast at anew-insight.com. To watch this episode on YouTube, visit @my.anew.insight. Follow us on social media at @my.anew.insight on Facebook, Instagram, TikTok, and Threads for more updates and insights. Thank you for tuning in! Stay connected with us for more empowering stories and expert guidance. Until next time, stay well and keep evolving with ANEW Body Insight!

Transcript

Dr. Supatra Tovar: 0:00

Welcome back to the ANEW Insight podcast. We are back for the second half of our interview with board certified neurosurgeon and visionary founder of ReCELLebrate Dr. Jeff Gross. Jeff gave us some invaluable insight into his inspiration to found ReCELLebrate. I am so excited to learn more. This is excellent stuff.

Dr. Jeff Gross: 0:01

I mean, yes. One, one of the applications theoretically would be to take people who are at high genetic risk or even high epigenetic risk like , they've been exposed to things that they shouldn't have been, and maybe they worked in a coal mine and they've got, potential for cancer that's higher than the, than the average bear. Yeah, I mean, amazing research again, mostly out of Europe and China as we discussed in our first half. But these, these are people with circulating tumor cells. So sometimes those are bloodborne cancers like leukemia, things like that have had wonderful results there. Also with solid tumors, injecting solid tumors, liver, breasts, or even some brain tumors that have been. Having amazing results, again, without chemotherapy, without radiation therapy, without known side effects showing, just these solid tumors shrinking. And I mean, that's why we wanted to get our hands on these. We think this is a tool we should offer to people. I mean, one of, one of my jobs is not only to relieve suffering and help people with pain, but you know, protect their rights to access to things that are difficult to get so. Since there are no known harm of this type of thing and the results are good and there's medical evidence to back it up, we want to do that for people. When I obtained the first 10 doses of the NK exosomes, there were 40 available from, from that source. Now, I'm not saying ignore chemotherapy, it's wrong. I'm not saying that. But you should know about all options and you might. Combine some options. You might use some traditional and some of these natural and cutting edge therapies as well. Well, I mean, we are seeing, and studies are arising that ivermectin combined with either mebendazole or   fenbendazole, which are anti antibiotics, anti-parasitics, can have a cancer reducing effect. There, there's some discussion of where the dose is or how to use it, and a lot of people who are interested in alternative protocols for cancer or augmentative protocols adding to a traditional approach that they can have these things. They have little downside, and we have had ivermectin around and animals get it, and I see people online that are buying it from, tractor supply because

Dr. Supatra Tovar: 0:06

Yes. I think it's so exciting to hear about this. Gimme a, a picture too of the primary barriers to widespread access to NK cell derived exosomes. And how have you been able to overcome them at ReCELLebrate? Wow. So what needs to happen to make this treatment more accessible to most people? Yes. Can we do that for dogs too? I just had to see my dog through radiation and chemotherapy, and luckily he's fine, but I can assume that maybe that will be available for vets as well someday.

Dr. Jeff Gross: 0:09

Most of my, my success stories have come from using. Regular stem cell derived exosomes. We treat, many other things all the way from joint degeneration, helping people avoid knee replacement surgery Well, we talked about stem cells and of course, stem cell, ex derived exosomes being immunomodulatory. We need that. We're also seeing, interestingly, supporting your bone. I, I said earlier, supporting your bone density and your muscle mass are correlated with longevity to, so supporting your bone density is because you're supporting your own stem cell system, right? So if you have osteoporosis, your bones are being bleached out and you, your bone marrow is converting into fat, Or red, to yellow bone marrow conversion and that. That means you have fewer stem cells. So we do have improvement in, in, when, when we infuse stem cell derived exosomes into people, we have improvement sometimes in their bone density.

Dr. Supatra Tovar: 0:12

That's incredible, but you don't hear about it at all. You hear, if somebody breaks their hip, they have to have a hip replacement. They've got something going on with their knee, they need surgery. Is it the same kind of forces at work against these therapies from industries that don't want this stuff out there?

Dr. Jeff Gross: 0:13

That's the number one thing we address at my practice is osteoarthritis, which is degeneration of joints. We take people who are bone on bone who are looking at knee replacement or some kind of joint replacement and we try to help them not need that anymore, put it off. There's always gonna be some role for surgery.

Dr. Supatra Tovar: 0:14

Oh, gotcha. I, I hear you. Okay, well now walk me through a typical if there is one biohacker and, and what they are wanting to do and how, what does the procedure look like? And if you if you are, feel comfortable enough, if you telling us what it might cost, the biohacker walk us through their, their treatment.

Dr. Jeff Gross: 0:15

We look at all of that and then, and only then if there's still issues we want to deal with and might just be preventative, then we look at the regenerative side of things and we have access to stem cells, we have access to PRP, we have access to exosomes. Not generally unless they have a health savings account or a flexible spending account where they get to control the health dollars. So, a starting dose might be five ccs, which is about 1.3 trillion exosome particles by count. Plus it has growth factors and. All the goodness of PRP and amniotic fluid, which amniotic fluid's magic, right? I mean, if And we're, we're down the chain in the, in the process. You, a 10 cc dose is not twice as much. It, it goes up a little less just because, it's, it's the economy of scale. When my mother and stepfather come in, they, they split 15 ccs,

Dr. Supatra Tovar: 0:19

and that's, that's how the younger people are seeing it.

Dr. Jeff Gross: 0:20

she'll tell you the same she's actually a, a poster child because she had knee issues going way back, old skiing injuries. So we're, we've got other things we do. We just, we'd have to have a third or fourth podcast to get into those. I. The but you search it, search on the internet, you will find, in your city, type in. Regenerative medicine, you're in Southern California so you'll, there are, I have colleagues that practice this there as well and we all come at it maybe a little bit different and that's okay. A lot of doctors do anyway. I think one of the holdbacks here will be big pharma is starting to get their fingers in it because they wanna monetize it, so that'll raise the price of it, sadly. And you, we see that already on the cancer side of things. There's a, there's another regenerative cancer treatment called CAR T-Cell which is like chimeric ac antigen rece receptor T-cell, which is a very laborious process.

Dr. Supatra Tovar: 0:23

Wow. Do you see people skirting around that maybe by going over to Asia or to Europe at this point? Wow, this is amazing. So we sadly are out of time, but we may have to have a third podcast 'cause I could, ask you a million questions moving forward. But how do people get ahold of you and how do they work with you? They can just pop over to Vegas somehow. So give, give all your information. Oh, awesome. Okay. We will put that in the show notes. Everyone oh my gosh. You could get a free consult with Dr. Jeff, who's amazing, and I tell you, you, you do look youthful, you do look healthy, you do look fit. And I'm sure your wife is absolutely gorgeous and you guys are really optimizing longevity science to help you age Hopefully it'll be as good as this one. Thank you and stay tuned and we'll see you next time.